Literature DB >> 16436073

A recombinant Mycobacterium tuberculosis in vitro transcription system.

Jean-François Jacques1, Sébastien Rodrigue, Ryszard Brzezinski, Luc Gaudreau.   

Abstract

In vitro transcription constitutes an important tool in the study of the regulation of gene expression. Here, we present a fast and easy procedure to prepare Mycobacterium tuberculosis RNA polymerase for in vitro transcription assays. RNA polymerase is assembled from recombinant proteins expressed in Escherichia coli, thus eliminating the need for biosafety containment facilities, and is mixed with any of the 13 M. tuberculosissigma factors. We show that the recombinant RNA polymerase is free from contaminating sigma factors, produces transcriptional start sites matching those characterized in vivo and allows the formal identification of sigma factors involved in the expression of genes of interest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436073     DOI: 10.1111/j.1574-6968.2005.00071.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Genome-wide definition of the SigF regulon in Mycobacterium tuberculosis.

Authors:  Ruben C Hartkoorn; Claudia Sala; Swapna Uplekar; Philippe Busso; Jacques Rougemont; Stewart T Cole
Journal:  J Bacteriol       Date:  2012-02-03       Impact factor: 3.490

2.  Sigma factor F does not prevent rifampin inhibition of RNA polymerase or cause rifampin tolerance in Mycobacterium tuberculosis.

Authors:  Ruben C Hartkoorn; Claudia Sala; Sophie J Magnet; Jeffrey M Chen; Florence Pojer; Stewart T Cole
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

3.  Posttranslational regulation of Mycobacterium tuberculosis extracytoplasmic-function sigma factor sigma L and roles in virulence and in global regulation of gene expression.

Authors:  Elisa Dainese; Sébastien Rodrigue; Giovanni Delogu; Roberta Provvedi; Liette Laflamme; Ryszard Brzezinski; Giovanni Fadda; Issar Smith; Luc Gaudreau; Giorgio Palù; Riccardo Manganelli
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

4.  Evidence of complex transcriptional, translational, and posttranslational regulation of the extracytoplasmic function sigma factor sigmaE in Mycobacterium tuberculosis.

Authors:  Valentina Donà; Sébastien Rodrigue; Elisa Dainese; Giorgio Palù; Luc Gaudreau; Riccardo Manganelli; Roberta Provvedi
Journal:  J Bacteriol       Date:  2008-07-07       Impact factor: 3.490

5.  Novel mechanism of gene regulation: the protein Rv1222 of Mycobacterium tuberculosis inhibits transcription by anchoring the RNA polymerase onto DNA.

Authors:  Paulami Rudra; Ranjit Kumar Prajapati; Rajdeep Banerjee; Shreya Sengupta; Jayanta Mukhopadhyay
Journal:  Nucleic Acids Res       Date:  2015-05-20       Impact factor: 16.971

6.  Production and characterization of a highly pure RNA polymerase holoenzyme from Mycobacterium tuberculosis.

Authors:  Omar Herrera-Asmat; Lucyna Lubkowska; Mikhail Kashlev; Carlos J Bustamante; Daniel G Guerra; Maria L Kireeva
Journal:  Protein Expr Purif       Date:  2017-03-18       Impact factor: 1.650

7.  Overproduction and purification of highly active recombinant Pseudomonas aeruginosa str. PAO1 RNA polymerase holoenzyme complex.

Authors:  Derrick Afful; Liming Cai; Cory Momany
Journal:  Protein Expr Purif       Date:  2019-07-04       Impact factor: 1.650

8.  Identification of mycobacterial sigma factor binding sites by chromatin immunoprecipitation assays.

Authors:  Sébastien Rodrigue; Joëlle Brodeur; Pierre-Etienne Jacques; Alain L Gervais; Ryszard Brzezinski; Luc Gaudreau
Journal:  J Bacteriol       Date:  2006-12-08       Impact factor: 3.490

9.  Association of ω with the C-Terminal Region of the β' Subunit Is Essential for Assembly of RNA Polymerase in Mycobacterium tuberculosis.

Authors:  Chunyou Mao; Yan Zhu; Pei Lu; Lipeng Feng; Shiyun Chen; Yangbo Hu
Journal:  J Bacteriol       Date:  2018-05-24       Impact factor: 3.490

10.  Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).

Authors:  Wei Lin; Kalyan Das; David Degen; Abhishek Mazumder; Diego Duchi; Dongye Wang; Yon W Ebright; Richard Y Ebright; Elena Sineva; Matthew Gigliotti; Aashish Srivastava; Sukhendu Mandal; Yi Jiang; Yu Liu; Ruiheng Yin; Zhening Zhang; Edward T Eng; Dennis Thomas; Stefano Donadio; Haibo Zhang; Changsheng Zhang; Achillefs N Kapanidis; Richard H Ebright
Journal:  Mol Cell       Date:  2018-03-29       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.